These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20544053)

  • 21. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic neuropathy: new strategies for treatment.
    Várkonyi T; Kempler P
    Diabetes Obes Metab; 2008 Feb; 10(2):99-108. PubMed ID: 17593238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
    Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K
    Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles.
    Forde G
    J Fam Pract; 2007 Feb; 56(2 Suppl Pain):3-12. PubMed ID: 17270113
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination pharmacotherapy for the treatment of neuropathic pain in adults.
    Chaparro LE; Wiffen PJ; Moore RA; Gilron I
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD008943. PubMed ID: 22786518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.
    Boyle J; Eriksson ME; Gribble L; Gouni R; Johnsen S; Coppini DV; Kerr D
    Diabetes Care; 2012 Dec; 35(12):2451-8. PubMed ID: 22991449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evidence-based pharmacotherapy of neuropathic pain syndromes].
    Braune S
    MMW Fortschr Med; 2004 Dec; 146(50):49-51. PubMed ID: 15658522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized, double-blind, comparative study.
    Memeo A; Loiero M
    Clin Drug Investig; 2008; 28(8):495-500. PubMed ID: 18598095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
    Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
    Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain.
    Sun P; Zhao Y; Zhao Z; Bernauer M; Watson P
    Pain Pract; 2012 Nov; 12(8):641-8. PubMed ID: 22335435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.
    Ogawa S; Satoh J; Arakawa A; Yoshiyama T; Suzuki M
    Drug Saf; 2012 Oct; 35(10):793-806. PubMed ID: 22967187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perineural Platelet-Rich Plasma for Diabetic Neuropathic Pain, Could It Make a Difference?
    Hassanien M; Elawamy A; Kamel EZ; Khalifa WA; Abolfadl GM; Roushdy ASI; El Zohne RA; Makarem YS
    Pain Med; 2020 Apr; 21(4):757-765. PubMed ID: 31298289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the management of diabetic peripheral neuropathy.
    Tesfaye S
    Curr Opin Support Palliat Care; 2009 Jun; 3(2):136-43. PubMed ID: 19421063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral neuropathy in persons with diabetes.
    Handevidt F
    Clin Excell Nurse Pract; 2001; 5(1):17-20. PubMed ID: 11154389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy.
    Ziegler D; Fonseca V
    J Diabetes Complications; 2015; 29(1):146-56. PubMed ID: 25239450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burning through the pain: treatments for diabetic neuropathy.
    Javed S; Alam U; Malik RA
    Diabetes Obes Metab; 2015 Dec; 17(12):1115-25. PubMed ID: 26179288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duloxetine for the management of diabetic peripheral neuropathic pain: response profile.
    Pritchett YL; McCarberg BH; Watkin JG; Robinson MJ
    Pain Med; 2007; 8(5):397-409. PubMed ID: 17661853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
    Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New perspectives on the management of diabetic peripheral neuropathic pain.
    Jensen TS; Backonja MM; Hernández Jiménez S; Tesfaye S; Valensi P; Ziegler D
    Diab Vasc Dis Res; 2006 Sep; 3(2):108-19. PubMed ID: 17058631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.